Display options
Share it on

Addict Health. 2019 Apr;11(2):120-128. doi: 10.22122/ahj.v11i2.232.

Comparing the Effects of Methadone, Buprenorphine, and Opium Tincture Maintenance Therapy on Sexual Function.

Addiction & health

Ali Kheradmand, Ahad Fazeli, Azadeh Mazaheri Meybodi

Affiliations

  1. Taleghani Hospital Research Development Committee AND Department of Psychiatry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  2. Department of Psychiatry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 31321009 PMCID: PMC6633070 DOI: 10.22122/ahj.v11i2.232

Abstract

BACKGROUND: Opioid use disorder is a major concern to public health, and opioid maintenance treatment on methadone or buprenorphine is a widely used approach. On the other hand, in recent years, there has been more regards for the use of opium tincture for detoxification and maintenance treatment of opioid dependence in certain parts of the world. The purpose of our research was to compare sexual impairments of methadone maintenance treatment (MMT), buprenorphine maintenance treatment (BMT), and opium tincture maintenance treatment (OMT) in patients.

METHODS: The study sample consisted of opium-addicted men candidates for maintenance treatment in an addiction quitting clinic in Tehran, Iran, from November 2017 to February 2018. Participants (n = 84) were randomly assigned to three groups (of the equal number), receiving either methadone tablet, buprenorphine sublingual tablet, and opium tincture. The average score for sexual function was evaluated using the Arizona Sexual Experiences Scale (ASEX) at the beginning and after 3 months after treatment.

FINDINGS: Although there was no significant different in ASEX scores between the groups at the beginning and end of the study (P > 0.05), but the difference was significant in each group in comparing by themselves.

CONCLUSION: These results showed that sexual dysfunction became better after opioid substitution therapies, and no differences were observed on sexual dysfunction between the three groups.

Keywords: Buprenorphine; Methadone; Opioid substitution therapies; Opium tincture; Sexual dysfunctions

References

  1. Arch Androl. 1999 Nov-Dec;43(3):189-96 - PubMed
  2. Am J Epidemiol. 2000 Sep 15;152(6):533-41 - PubMed
  3. N Engl J Med. 2000 Nov 2;343(18):1290-7 - PubMed
  4. Endocr Rev. 2001 Jun;22(3):342-88 - PubMed
  5. Public Health Rep. 2002;117 Suppl 1:S135-45 - PubMed
  6. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S13-27 - PubMed
  7. Arch Sex Behav. 2003 Jun;32(3):279-85 - PubMed
  8. Br J Clin Pharmacol. 2004 Nov;58(5):536-41 - PubMed
  9. J Addict Dis. 2005;24(2):91-106 - PubMed
  10. Arch Sex Behav. 2005 Dec;34(6):613-26 - PubMed
  11. Int J Androl. 2009 Apr;32(2):131-9 - PubMed
  12. Drug Alcohol Depend. 2008 Apr 1;94(1-3):12-8 - PubMed
  13. J Pharmacol Exp Ther. 1991 Mar;256(3):1086-93 - PubMed
  14. J Urol. 1991 Apr;145(4):759-63 - PubMed
  15. Int J Drug Policy. 2010 Mar;21(2):119-21 - PubMed
  16. J Sex Med. 2010 Apr;7(4 Pt 2):1668-86 - PubMed
  17. J Sex Med. 2012 Dec;9(12):3198-204 - PubMed
  18. Addict Behav. 2012 Jan;37(1):124-6 - PubMed
  19. J Addict Med. 2012 Sep;6(3):212-8 - PubMed
  20. Psychol Health Med. 2013;18(3):321-9 - PubMed
  21. Med Arch. 2013;67(1):48-50 - PubMed
  22. Hepat Mon. 2013 Apr 16;13(4):e8334 - PubMed
  23. J Sex Med. 2014 Jan;11(1):22-32 - PubMed
  24. Brain Res. 1988 Apr 26;447(1):200-3 - PubMed
  25. Drug Alcohol Depend. 2015 Apr 1;149:1-9 - PubMed
  26. PLoS One. 2016 Jan 28;11(1):e0147852 - PubMed
  27. J Sex Med. 2016 Sep;13(9):1377-1386 - PubMed
  28. Nephrourol Mon. 2016 Jul 03;8(4):e38052 - PubMed
  29. Med Clin (Barc). 2017 Jul 21;149(2):49-54 - PubMed
  30. Am J Drug Alcohol Abuse. 1977;4(1):13-20 - PubMed
  31. Endocrinology. 1980 Jun;106(6):1917-22 - PubMed
  32. J Urol. 1994 Jan;151(1):54-61 - PubMed
  33. J Sex Marital Ther. 1997 Fall;23(3):212-20 - PubMed
  34. J Pharmacol Exp Ther. 1976 Aug;198(2):340-6 - PubMed

Publication Types